ACSL4 Cancer Research Results

ACSL4, Acyl-CoA Synthetase Long-Chain Family Member 4: Click to Expand ⟱
Source:
Type:
ACSL4 (Acyl-CoA Synthetase Long-Chain Family Member 4) is a protein that plays a crucial role in the regulation of fatty acid metabolism, particularly in the context of cancer.
ACSL4 has been shown to be highly expressed in various types of cancer.


Scientific Papers found: Click to Expand⟱
5434- AG,    Recent Advances in the Mechanisms and Applications of Astragalus Polysaccharides in Liver Cancer Treatment: An Overview
- Review, Liver, NA
AntiCan↑, Apoptosis↑, TumCP↓, EMT↓, Imm↑, ChemoSen↑, BioAv↓, TumCG↓, IL2↑, IL12↑, TNF-α↑, P-gp↓, MDR1↓, QoL↑, Casp↑, DNAdam↑, Bcl-2↓, BAX↑, MMP↓, Cyt‑c↑, NOTCH1↓, GSK‐3β↓, TumCCA↑, GSH↓, ROS↑, lipid-P↑, c-Iron↑, GPx4↓, ACSL4↑, Ferroptosis↑, Wnt↓, β-catenin/ZEB1↓, cycD1/CCND1↓, Akt↓, PI3K↓, mTOR↓, CXCR4↓, Vim↓, PD-L1↓, eff↑, eff↑, ChemoSen↑, ChemoSen↑, chemoP↑,
575- ART/DHA,    Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
- in-vitro, GBM, U87MG
GPx4↓, xCT∅, ROS↑, Ferroptosis↑, ACSL4∅,
2625- Ba,  LT,    Baicalein and luteolin inhibit ischemia/reperfusion-induced ferroptosis in rat cardiomyocyte
- in-vivo, Stroke, NA
*lipid-P↓, *ACSL4∅, *NRF2∅, *GPx4∅, *Ferroptosis↓, *ROS↓, *MDA↓, *eff↑, *HO-1∅,
5680- BML,    Anticancer properties of bromelain: State-of-the-art and recent trends
- Review, Var, NA
*Inflam↓, *Bacteria↓, *Pain↓, *Diar↓, *Wound Healing↑, ERK↓, JNK↓, XIAP↓, HSP27↓, β-catenin/ZEB1↓, HO-1↓, lipid-P↓, ACSL4↑, ROS↑, SOD↑, Catalase↓, GSH↓, MDA↓, Casp3↓, Casp9↑, DNAdam↑, Apoptosis↑, NF-kB↓, P53↑, MAPK↓, APAF1↑, Cyt‑c↓, CD44↓, Imm↑, ATG5↑, LC3I↑, Beclin-1↑, IL2↓, IL4↓, IFN-γ↓, COX2↓, iNOS↓, ChemoSen↑, RadioS↑, Dose↝, other↓,
739- Bor,    Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells
- in-vitro, GBM, U87MG - in-vitro, Nor, HMC3
TumCG↓, TumCP↓, TumCCA↑, PCBP1↓, GSH↓, GPx4↓, Beclin-1↑, MDA↑, ACSL4↑, Casp3↑, Casp7↑, Ferroptosis↑, *toxicity↓,
3215- EGCG,    Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer
- in-vitro, NSCLC, A549 - in-vitro, NSCLC, H1299
TumCP↓, Ki-67↓, GPx4↓, ACSL4↑, Iron↑, MDA↑, ROS↑, Ferroptosis↑, eff↑, NRF2↑, HO-1↑,
4965- PSO,  Cisplatin,    The synergistic antitumor effects of psoralidin and cisplatin in gastric cancer by inducing ACSL4-mediated ferroptosis
- vitro+vivo, GC, HGC27 - vitro+vivo, GC, MKN45
TumCP↓, TumCMig↓, TumCI↓, TumCG↓, *toxicity↓, eff↑, Ferroptosis↑, ACSL4↑, GPx4↓, ChemoSen↑, chemoP↑, AntiTum↑, Sepsis↓,
3039- RosA,    Rosmarinic acid liposomes suppress ferroptosis in ischemic brain via inhibition of TfR1 in BMECs
- in-vivo, Nor, NA - in-vivo, Stroke, NA
*Ferroptosis↓, *GPx4↑, *ACSL4↓, *BBB↑, *IronCh↑, *TfR1/CD71↓, *neuroP↑,

Showing Research Papers: 1 to 8 of 8

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

Catalase↓, 1,   Ferroptosis↑, 5,   GPx4↓, 5,   GSH↓, 3,   HO-1↓, 1,   HO-1↑, 1,   Iron↑, 1,   c-Iron↑, 1,   lipid-P↓, 1,   lipid-P↑, 1,   MDA↓, 1,   MDA↑, 2,   NRF2↑, 1,   ROS↑, 4,   SOD↑, 1,   xCT∅, 1,  

Mitochondria & Bioenergetics

MMP↓, 1,   XIAP↓, 1,  

Core Metabolism/Glycolysis

ACSL4↑, 5,   ACSL4∅, 1,  

Cell Death

Akt↓, 1,   APAF1↑, 1,   Apoptosis↑, 2,   BAX↑, 1,   Bcl-2↓, 1,   Casp↑, 1,   Casp3↓, 1,   Casp3↑, 1,   Casp7↑, 1,   Casp9↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 1,   Ferroptosis↑, 5,   iNOS↓, 1,   JNK↓, 1,   MAPK↓, 1,  

Transcription & Epigenetics

other↓, 1,  

Protein Folding & ER Stress

HSP27↓, 1,  

Autophagy & Lysosomes

ATG5↑, 1,   Beclin-1↑, 2,   LC3I↑, 1,  

DNA Damage & Repair

DNAdam↑, 2,   P53↑, 1,  

Cell Cycle & Senescence

cycD1/CCND1↓, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

CD44↓, 1,   EMT↓, 1,   ERK↓, 1,   GSK‐3β↓, 1,   mTOR↓, 1,   NOTCH1↓, 1,   PI3K↓, 1,   TumCG↓, 3,   Wnt↓, 1,  

Migration

Ki-67↓, 1,   PCBP1↓, 1,   TumCI↓, 1,   TumCMig↓, 1,   TumCP↓, 4,   Vim↓, 1,   β-catenin/ZEB1↓, 2,  

Barriers & Transport

P-gp↓, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   CXCR4↓, 1,   IFN-γ↓, 1,   IL12↑, 1,   IL2↓, 1,   IL2↑, 1,   IL4↓, 1,   Imm↑, 2,   NF-kB↓, 1,   PD-L1↓, 1,   TNF-α↑, 1,  

Drug Metabolism & Resistance

BioAv↓, 1,   ChemoSen↑, 5,   Dose↝, 1,   eff↑, 4,   MDR1↓, 1,   RadioS↑, 1,  

Clinical Biomarkers

Ki-67↓, 1,   PD-L1↓, 1,  

Functional Outcomes

AntiCan↑, 1,   AntiTum↑, 1,   chemoP↑, 2,   QoL↑, 1,  

Infection & Microbiome

Sepsis↓, 1,  
Total Targets: 86

Pathway results for Effect on Normal Cells:


NA, unassigned

Diar↓, 1,  

Redox & Oxidative Stress

Ferroptosis↓, 2,   GPx4↑, 1,   GPx4∅, 1,   HO-1∅, 1,   lipid-P↓, 1,   MDA↓, 1,   NRF2∅, 1,   ROS↓, 1,  

Metal & Cofactor Biology

IronCh↑, 1,   TfR1/CD71↓, 1,  

Core Metabolism/Glycolysis

ACSL4↓, 1,   ACSL4∅, 1,  

Cell Death

Ferroptosis↓, 2,  

Barriers & Transport

BBB↑, 1,  

Immune & Inflammatory Signaling

Inflam↓, 1,  

Drug Metabolism & Resistance

eff↑, 1,  

Functional Outcomes

neuroP↑, 1,   Pain↓, 1,   toxicity↓, 2,   Wound Healing↑, 1,  

Infection & Microbiome

Bacteria↓, 1,  
Total Targets: 22

Scientific Paper Hit Count for: ACSL4, Acyl-CoA Synthetase Long-Chain Family Member 4
1 Astragalus
1 Artemisinin
1 Baicalein
1 Luteolin
1 Bromelain
1 Boron
1 EGCG (Epigallocatechin Gallate)
1 Psoralidin
1 Cisplatin
1 Rosmarinic acid
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:867  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page